Indogulf Cropsciences Ltd.

IGCL

Equity

NSE,BSE

Min. Investment

1,05,000.00

Open a free Demat account and invest in IPOs easily.

Download Orca

Google PlayApp Store

To access realtime data for GP Eco Solutions India Ltd. and use advance features for Applying IPO. Register or Login to Orca.

IPO Details

Bidding Dates

26 Jun 25 - 30 Jun 25

Lot Size

135

Price Range ₹

105 - 111

Exchange Status

NSE,BSE

Total Equity

0.00Cr

IPO Doc

IPO Timeline

Offer start

26 Jun 2025

Offer end

30 Jun 2025

Allotment

01 Jul 2025

Refund initiation

02 Jul 2025

Demat transfer

02 Jul 2025

Listing

03 Jul 2025

About Company

Incorporated in 1993, Indogulf Cropsciences Limited is a leading Indian agrochemical company engaged in the manufacturing of crop protection products, plant nutrients, and biologicals. With four manufacturing facilities across Haryana and Jammu & Kashmir, the company offers a diverse product portfolio including insecticides, fungicides, herbicides, bio-stimulants, and specialty fertilizers. Indogulf serves both retail and institutional clients through a strong distribution network spread across 22 Indian states, 3 Union Territories, and 34 international markets. It combines in-house production with third-party formulation to optimize efficiency, and it’s backed by strong R&D, experienced promoters, and scalable infrastructure. The company is well-positioned to benefit from rising agrochemical demand, both domestically and globally, as India emerges as a key manufacturing hub.

Year Founded

22-01-1993

Promotor Details

Om Prakash Aggarwal

Promoter Holdings Details

ParticularPre-IPOPost-IPO
Percentage96.870
Share Capital472596880
0

Highlights

  • Offers a wide range of crop protection products, plant nutrients, and biologicals, catering to various agricultural needs.
  • Presence in 22 states, 3 Union Territories, and 34 international markets ensures broad market access and customer reach.
  • In-house technical manufacturing enhances cost control, product quality, and reduces dependency on external suppliers.
  • Robust product development and regulatory pipeline support future growth in high-margin patented and biosolution segments.
  • Growing agrochemical demand, low pesticide use per hectare in India, and global outsourcing shifts from China create strong tailwinds.

Challenges

  • Total debt increased significantly from ₹101.38 Cr in FY22 to ₹206.30 Cr in Dec 2024, which may impact financial flexibility.
  • Revenue declined from ₹555.79 Cr in FY24 to ₹466.31 Cr as of Dec 2024, indicating inconsistent sales trends.
  • Hybrid model with long collection cycles may strain working capital and cash flow stability.
  • Operations are subject to stringent regulatory approvals in domestic and global markets, which can delay product launches.
  • Operates in a highly competitive agrochemical space with pressure from global and domestic players on pricing and innovation.
Enrich money logo